Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1365-2559.1991.tb00823.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The clinical characteristics and treatment outcomes of patients with systemic polyarteritis nodosa (PAN): a single centre study from India.
Rheumatology (Oxford)
January 2025
Department of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, India.
Objectives: To describe the clinical profile and compare the long-term outcomes of patients with S-PAN treated with various treatment regimens at our centre in the last 2 decades.
Methods: Data regarding clinical presentation, treatment allocation, relapses and outcomes of patients fulfilling American College of Rheumatology (ACR) 1990 criteria for PAN in the last 2 decades were recorded from electronic medical records. Relapse-free survival and predictors were analysed using KM survival statistics and regression analysis.
Cutaneous Adverse Drug Reactions Associated with SGLT2 Inhibitors.
J Clin Med
December 2024
Department of Cardiology-Internal Medicine and Ambulatory Care, Prevention and Cardiovascular Recovery, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Diabetes is a complex global healthcare burden involving multiple organ systems with its prevalence on the rise. SGLT2 inhibitors enhance glucose excretion. The objective of our literature review was to determine the association between cutaneous adverse drug reactions (CADRs) and the use of SGLT2 inhibitors.
View Article and Find Full Text PDFA case of polyarteritis nodosa with severe lower limb ulcer that was treated with prednisolone and tocilizumab.
Mod Rheumatol Case Rep
December 2024
Nephrology Center and Okinaka Memorial Institute for Medical Research, Toranomon Hospital Kajigaya, Kanagawa, Japan.
Polyarteritis nodosa (PAN) is a rare systemic necrotizing vasculitis that can lead to the formation of refractory lower limb ulcers requiring amputation. The standard treatment for severe PAN involves combination therapy with steroids and cyclophosphamide; however, some cases prove to be challenging. Recently, case reports have described the use of biological agents for PAN treatment.
View Article and Find Full Text PDFAmputations Resulting From Systemic Sclerosis: The Role of Multidisciplinary Cooperation.
Cureus
October 2024
Physical Medicine and Rehabilitation, Unidade Local de Saúde de Santo António, Porto, PRT.
Systemic sclerosis (SSc) is a complex connective tissue disease involving microvasculopathy, immune dysregulation, and extensive organ fibrosis. It affects various systems including the skin, lungs, heart, and gastrointestinal tract. Management is challenging due to the disease's heterogeneity and often requires more than just pharmacological treatment.
View Article and Find Full Text PDFArticle Synopsis
- An 80-year-old man experienced worsening kidney function and mobility issues, presenting symptoms like livedo reticularis and gangrene in his legs.
- He was diagnosed with a cholesterol crystal embolism and initially treated with prednisolone and rosuvastatin, but this did not lead to any improvement.
- The patient then underwent a new treatment involving low-density lipoprotein apheresis, which led to improvements in his leg symptoms and allowed for the discontinuation of dialysis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!